Clinical Trials Browser

Phase 1/2 × Suspended × Doxorubicin × Clear all

NCT03704714 2022-08-15

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Phase 1/2 Suspended

Lymphoma, B-Cell